Abiopharma

Psyence is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. Our vision is that our enduring work expands access to mental wellness and nurtures community. We will achieve this by developing and providing innovative, safe and effective psychedelic and nature-centred solutions for mental health and palliative care.

Additional info from NASDAQ:
Psyence Biomedical Ltd. (Nasdaq: PBM) is the worlds first life science biotechnology company focused on the development of botanical (nature derived, or non-synthetic) psilocybin-based psychedelic medicine to be listed on Nasdaq. The name Psyence combines the words psychedelics and science to affirm Psyence Biomeds commitment to an evidence-based approach to innovation as it works to develop safe and effective, nature-derived psychedelic therapeutics to treat a broad range of mental health disorders. The Company is initially focused on mental health disorders in the context of Palliative Care.

Additional info from OTC:
Psyence is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. Our vision is that our enduring work expands access to mental wellness and nurtures community. We will achieve this by developing and providing innovative, safe and effective psychedelic and nature-centred solutions for mental health and palliative care.